Control Bionics (ASX:CBL) Ending Cash Position : A$0.97 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Ending Cash Position?

Control Bionics's Ending Cash Position for the quarter that ended in Dec. 2024 was A$0.97 Mil.

Control Bionics's quarterly Ending Cash Position declined from Dec. 2023 (A$1.31 Mil) to Jun. 2024 (A$0.98 Mil) and declined from Jun. 2024 (A$0.98 Mil) to Dec. 2024 (A$0.97 Mil).

Control Bionics's annual Ending Cash Position declined from Jun. 2022 (A$5.21 Mil) to Jun. 2023 (A$0.94 Mil) but then increased from Jun. 2023 (A$0.94 Mil) to Jun. 2024 (A$0.98 Mil).

Control Bionics Ending Cash Position Historical Data

The historical data trend for Control Bionics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Ending Cash Position Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

12.33

5.21

0.94

0.98

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial				3.03	0.94	1.31	0.98	0.97

Control Bionics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Control Bionics's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.935	+	0.046
	=	0.98

Control Bionics's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.98	+	-0.008
	=	0.97

Control Bionics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Control Bionics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.